Outsourced Radiology Services Outsourced Radiology Services

HRCT: An efficient primary diagnostic test for COVID-19 pneumonia – An Indian perspective

RT-PCR has been the testing protocol for diagnosis of COVID-19; shortcomings include limited availability, long turn-around times, and false-negative reports indicating that sensitivity remains around 70%. Previous researchers have shown that the false-negative ratio of RT-PCR test for patients infected with COVID-19 is approximately 1 in 5. HRCT has been widely accepted for prognostication of COVID-19 pneumonia. Tests were conducted on people who were either index cases who had been recently diagnosed for COVID-19 or patients whose testing was performed and results awaited but were clinically symptomatic. HRCT was deemed “positive” for diagnosis of COVID-19 pneumonia if either one or a combination of several well-described signs were seen—including but not limited to ground-glass opacities in typical peripheral sub pleural distribution, sub pleural/interlobular interstitial thickening, atoll sign, halo and reverse halo signs, to name a few. Further, CT severity index was evaluated for the patients who had a “positive” HRCT to assess the severity in these patients. 

In places where the prevalence of pandemic is high, a fast, non-invasive, accurate, and inexpensive test for screening and diagnosis is essential. The sensitivity of HRCT, when compared with RT-PCR, has been previously studied and was shown to be higher than RT-PCR. This study has proven that HRCT is a very useful tool for the initial diagnosis of patients suspected to have COVID-19 irrespective of symptoms or day of onset of CT. Considering the many overall advantages, HRCT for the chest deserves to be included in the official diagnostic guidelines for diagnosis.

Partner with us

AMI Expertise - When You Need It, Where You Need It.

Partner With Us